COMP <GO>
WRBY vs LLY // PIOTROSKI F-SCORE QUALITY
Warby Parker Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: WRBY 1
— LLY 12
■ METRIC PARITY
LAST: $24.61 (+0.08%) • MKT CAP: $3.04B
piotroski-score
9/9
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
piotroski-score
9/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WRBY VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WRBY | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.00% | 83.64% | -29.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.70% | 32.36% | -34.06 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.44% | 2.30% | -0.86 | LLY | /fcf-yield <GO> |
| Operating Margin | -0.60% | 40.21% | -40.81 | LLY | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 31.90% | -31.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 45.51% | -32.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.35 | 9.29 | -3.94 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.77% | +0.63 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 77.9 | -31.95 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.14 | 0.51 | +0.63 | WRBY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 26.3x | +113.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WRBY REV | LLY REV | WRBY GROSS % | LLY GROSS % | WRBY FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $871.9M | $65.18B | 54.0% | 83.0% | $43.7M | $16.81B |
| FY 2024 | $771.3M | $45.04B | 55.3% | 81.3% | $34.7M | $8.82B |
| FY 2023 | $669.8M | $34.12B | 44.0% | 79.3% | $30.9M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WRBY // BETA 1.14
LLY // BETA 0.51